B+
Bull case
25%
Probability
Target price
$58.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
OMCL
OmnicellANasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Q2 execution was solid, with 7% revenue growth, strong profitability, and higher FY2026 EBITDA and EPS guidance. Demand for connected devices, SaaS, technical services, Titan XT, and enterprise medication-management capabilities supports a constructive medium-term case [#SEC-8K-2026-07-30].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +14.5.
What can break
Customer approval and contracting delays could defer product bookings beyond 2026.
Momentum
8
Value
66
Sentiment
100
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $45.00 · Bull $58.00 · Bear $28.00Analysis 2026-09-03; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $57.86
Why
Momentum8 · Δ7d +1.1
Value66 · Δ7d -0.0
Sentiment100 · Δ7d +14.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +14.5.
Contradictions & invalidation
- • Customer approval and contracting delays could defer product bookings beyond 2026.
- • OmniSphere availability and monetization are targeted for H1 2027, leaving substantial execution and timing risk.
- • The lower end of product-bookings guidance was reduced because customer decisions, approvals, and contracting cycles are slipping.
Catalyst clock
2026-09-30
Q2 profitability supports near-term sentiment, but bookings timing limits upside
Lead driver: Sentiment · See AI snapshot
Momentum
8
9% active weight
Current posture
7d trendImproving
Δ7d
+1.1
Δ21d
+3.8
Value
66
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+4.8
Sentiment
100
62% active weight
Current posture
7d trendImproving
Δ7d
+14.5
Δ21d
+14.9
Why this grade
Composite grade A. Momentum 7.9 / Value 66.0 / Sentiment 100.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-03. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$45.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$28.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.64B
Beta
0.78
Shares Out
45.61M
P/E (TTM)
110.7
P/S (TTM)
1.79
P/FCF (TTM)
22.46
Rev YoY
+7.4%
EPS YoY
+337.2%
Gross Margin
+44.8%
Op Margin
+4.7%
Net Debt
-$46.69M
Current Ratio
1.61
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data